MIM
NUVB icon

MetLife Investment Management’s Nuvation Bio NUVB Stock Holding History

MetLife Investment Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$549K Sell
127,912
-10,266
-7% -$57.2K ﹤0.01% 1706
2025
Q4 		$1.24M Sell
138,178
-9,683
-7% -$60K 0.01% 1307
2025
Q3 		$547K Sell
147,861
-6,168
-4% -$16.8K ﹤0.01% 1765
2025
Q2 		$300K Buy
154,029
+64,694
+72% +$135K ﹤0.01% 1959
2025
Q1 		$157K Sell
89,335
-14,312
-14% -$32.6K ﹤0.01% 2318
2024
Q4 		$276K Buy
103,647
+12,596
+14% +$32.4K ﹤0.01% 2128
2024
Q3 		$209K Sell
91,051
-14,627
-14% -$44.6K ﹤0.01% 2266
2024
Q2 		$309K Buy
105,678
+20,287
+24% +$61.9K ﹤0.01% 1986
2024
Q1 		$311K Buy
85,391
+6,103
+8% +$11.7K ﹤0.01% 1942
2023
Q4 		$120K Hold
79,288
– – ﹤0.01% 2516
2023
Q3 		$106K Hold
79,288
– – ﹤0.01% 2549
2023
Q2 		$143K Buy
79,288
+12,996
+20% +$22.1K ﹤0.01% 2480
2023
Q1 		$110K Buy
66,292
+23,504
+55% +$47.6K ﹤0.01% 2506
2022
Q4 		$82.2K Sell
42,788
-22,051
-34% -$44.6K ﹤0.01% 2666
2022
Q3 		$145K Hold
64,839
– – ﹤0.01% 2479
2022
Q2 		$210K Sell
64,839
-24,836
-28% -$108K ﹤0.01% 2291
2022
Q1 		$472K Buy
89,675
+31,975
+55% +$180K ﹤0.01% 1805
2021
Q4 		$490K Buy
57,700
+32,149
+126% +$295K ﹤0.01% 1515
2021
Q3 		$254K Buy
25,551
+8,557
+50% +$77.6K ﹤0.01% 1937
2021
Q2 		$158K Buy
+16,994
New +$194K ﹤0.01% 2298

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MetLife Investment Management's NUVB Position: Q1 2026 in Review

MetLife Investment Management reduced its Nuvation Bio (NUVB) stake by 7.4% in Q1 2026, selling an estimated $57.2K and leaving 127,912 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

MetLife Investment Management first reported a position in NUVB in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.24M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • MetLife Investment Management held 127,912 shares of Nuvation Bio worth $549K as of Q1 2026.
  • MetLife Investment Management sold 10,266 Nuvation Bio shares in Q1 2026, an estimated $57.2K.
  • Nuvation Bio made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1706 holding.
  • MetLife Investment Management first reported a position in Nuvation Bio in Q2 2021 and has held it in 20 quarters since.
  • MetLife Investment Management's Nuvation Bio position peaked at $1.24M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.